Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Statement [Abstract]
Grant revenue	$ 87,586	$ 50,000	$ 183,025	$ 76,165
Operating expenses:
Research and development	4,025,940	6,339,993	14,360,293	14,380,415
General and administrative	3,342,266	2,387,585	10,238,744	7,386,007
Total operating expenses	7,368,206	8,727,578	24,599,037	21,766,422
Loss from operations	(7,280,620)	(8,677,578)	(24,416,012)	(21,690,257)
Other income (expense):
Other income		(13,129)		659,695
Interest income	6,119	12,051	19,184	41,619
Total other income (expense), net	6,119	(1,078)	19,184	701,314
Net loss	$ (7,274,501)	$ (8,678,656)	$ (24,396,828)	$ (20,988,943)
Net loss per share, basic and diluted (in Dollars per share)	$ (0.29)	$ (0.34)	$ (0.96)	$ (0.85)
Weighted average common shares outstanding, basic and diluted (in Shares)	25,451,691	25,371,781	25,399,352	24,635,350
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
Net loss	$ (7,274,501)	$ (8,678,656)	$ (24,396,828)	$ (20,988,943)
Other comprehensive loss:
Foreign currency translation adjustments	(103,226)	(53,498)	(161,426)	(118,790)
Comprehensive loss	$ (7,377,727)	$ (8,732,154)	$ (24,558,254)	$ (21,107,733)